X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
female (12) 12
index medicus (12) 12
male (12) 12
aged (11) 11
cardiac & cardiovascular systems (10) 10
medical and health sciences (10) 10
medicin och hälsovetenskap (10) 10
stroke (10) 10
abridged index medicus (9) 9
atrial fibrillation (9) 9
risk factors (9) 9
anticoagulants (8) 8
drug therapy (8) 8
middle aged (8) 8
warfarin (8) 8
aged, 80 and over (7) 7
anticoagulants - administration & dosage (6) 6
benzimidazoles - administration & dosage (6) 6
follow-up studies (6) 6
treatment outcome (6) 6
warfarin - administration & dosage (6) 6
atrial fibrillation - drug therapy (5) 5
beta-alanine - analogs & derivatives (5) 5
clinical medicine (5) 5
dabigatran (5) 5
hemorrhage - chemically induced (5) 5
klinisk medicin (5) 5
peripheral vascular disease (5) 5
prospective studies (5) 5
stroke - prevention & control (5) 5
usage (5) 5
aspirin (4) 4
atrial fibrillation - mortality (4) 4
benzimidazoles - adverse effects (4) 4
cardiac arrhythmia (4) 4
cardiovascular (4) 4
dabigatran etexilate (4) 4
embolism (4) 4
health aspects (4) 4
hemorrhage (4) 4
medical research (4) 4
research (4) 4
stroke - etiology (4) 4
stroke prevention (4) 4
time factors (4) 4
anticoagulants - adverse effects (3) 3
antithrombins - administration & dosage (3) 3
beta-alanine - administration & dosage (3) 3
care and treatment (3) 3
comparative analysis (3) 3
cryptogenic stroke (3) 3
direct thrombin inhibitor (3) 3
dosage and administration (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
etexilate (3) 3
incidence (3) 3
internal medicine (3) 3
medicine (3) 3
medicine, general & internal (3) 3
mortality (3) 3
prevention (3) 3
rivaroxaban (3) 3
thromboembolism (3) 3
warfarin - adverse effects (3) 3
3112 neurosciences (2) 2
3124 neurology and psychiatry (2) 2
age (2) 2
analysis (2) 2
anticoagulants - therapeutic use (2) 2
antithrombotic therapy (2) 2
apolipoproteins (2) 2
aspirin - therapeutic use (2) 2
atrial fibrillation - complications (2) 2
atrial fibrillation - therapy (2) 2
atrial-fibrillation (2) 2
beta-alanine - adverse effects (2) 2
brain ischemia - prevention & control (2) 2
cardiac and cardiovascular systems (2) 2
cardiac pacing, artificial - adverse effects (2) 2
cardiovascular disease (2) 2
cerebral embolism (2) 2
complications and side effects (2) 2
defibrillators (2) 2
defibrillators, implantable (2) 2
disease (2) 2
embolic stroke of undetermined source (2) 2
embolisms (2) 2
equipment design (2) 2
factor xa inhibitors - therapeutic use (2) 2
intracranial embolism - drug therapy (2) 2
ischemia (2) 2
kardiologi (2) 2
lipids (2) 2
medicin (2) 2
metaanalysis (2) 2
neurology (2) 2
non-inferiority trial (2) 2
pacemakers (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 12, pp. 1139 - 1151
Journal Article